Mikhailov & Partners in Working Group on Regulation of Pharmaceuticals Advertising
26 June 2012, Moscow – The head of Mikhailov & Partners’ Healthcare team Polina Belyaeva has been appointed to the working group on regulation of advertising in the pharmaceuticals sector.
The working group has been set up on the initiative of the Union of Professional Pharmaceutical Organizations (UPPO) and includes representatives of major international and Russian pharmaceutical producers, the medical community and analytical companies. Its objective is to work out an expert industry position on legal regulation of advertising in the pharmaceuticals sector, taking the interests of the pharmaceutical and medical communities and also patients into account. In particular, it will draw up joint proposals on draft amendments to Article 24 of the federal law on advertising, which establishes a complete ban on advertising medication. The working group is headed by Alexander Shibaev (of Novartis Consumer Health), a member of the UPPO’s Supervisory Board.